ATROPINE Solution for injection Ref.[8249] Active ingredients: Atropine

Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Mercury Pharmaceuticals Limited, Capital House, 85 King William Street, London, EC4N 7BL, UK

Product name and form

Atropine Sulphate 600 micrograms/ml Solution for Injection.

Pharmaceutical Form
Clear, colourless, sterile, aqueous solution intended for parenteral administration to human beings.

Qualitative and quantitative composition

Each 1ml of solution contains 600 micrograms of Atropine Sulphate B.P.

For the full list of excipients, see section 6.1.

Active Ingredient	Description
Atropine	Atropine is an antimuscarinic agent which competitively antagonises acetylcholine at postganglionic nerve endings, thus affecting receptors if the exocrine glands, smooth muscle, cardiac muscle and the central nervous system.

List of Excipients
Dilute sulphuric acid BP Water for injections BP (in bulk)

Pack sizes and marketing

1ml, clear One point cut (OPC) glass ampoules, glass Type I Ph. Eur. Borosilicate glass packed in cardboard cartons to contain 10 × 1ml ampoules.

Marketing authorization holder

Mercury Pharmaceuticals Limited, Capital House, 85 King William Street, London, EC4N 7BL, UK

Marketing authorization dates and numbers

PL 12762/0560

26/02/1991

Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.